Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on RuCl[(S,S) TsDPEN]. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104672189A details Ru-catalyzed asymmetric hydrogen transfer for high-purity chiral alcohols. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1926083B details a novel ruthenium-catalyzed asymmetric hydrogenation method for producing high-purity optically active alcohols with superior stereoselectivity and yield.
High-yield asymmetric hydrogenation patent CN1926083B enables cost-effective production of chiral alcohols for pharma intermediates with superior enantioselectivity.